current user: public

If you have questions about the server, please let us know.

Query: sp|Q8N6D5|ANR29_HUMAN Ankyrin repeat domain-containing protein 29 OS=Homo sapiens GN=ANKRD29 PE=2 SV=2, from H.sapiens

Results of FFAS03 search in PDB1018
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300
# Score Template Links and tools%idFirst MCRMSFKKETPLANAAFWAARRGNLALLKLLLNSGRVDVDCRDSHGTTLLMVAAYAGHIDCVRELVLQGADINLQRESGTTALFFAAQQGHNDVVRFLFGFGASTEFRTKDGGTALLAASQYGHMQVVETLLKHGANIHDQLYDGATALFLAAQGGYLDVIRLLLASGAKVNQPRQDGTAPLWIASQMGHSEVVRVMLLRGADRDAARNDGTTALLKAANKGYNDVIKELLKFSPTLGILKNGTSALHAAVLSGNIKTVALLLEAGADPSLRNKANELPAELTKNERILRLLRSKEGPRKSLast
1 -81.2005le3_A mol:protein length:317 DD_D12_09_D12  ali model follow..  33  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPGDLAAREGHREAVERAIKAGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 311
2 -80.6005le6_A mol:protein length:324 DD_D12_09_D12  ali model follow..  34  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVSAQDKFGKTPRDLAAREGHRDRVEKLIKAGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 318
3 -80.2004rly_A mol:protein length:329 Nav1.2 - AnkB chimera  ali model follow..  26  26PRGSKSDSNAS----FLRAARAGNLDKVVEYLKGG-IDINTCNQNGLNALHLAAKEGHVGLVQELLGRGSSVDSATKKGNTALHIASLAGQAEVVKVLVKEGANINAQSQNGFTPLYMAAQENHIDVVKYLLENGANQSTATEDGFTPLAVALQQGHNQAVAILLENDTKGK----VRLPALHIAARKDDTKSAALLLQNDHNVNRTTESGFTPLHIAAHYGNVNVATLLLNRGAAVDFTANGITPLHVASKRGNTNMVKLLLDRGGQIDAKTRDGLTPLHCAGHDQVVELLKVVTEEVTT 329
4 -80.2006ar6_B mol:protein length:328 DLD-4 darpin  ali model follow..  30  1.....SDLGKK----LLEAARAGQDDEVRILMANG-ADVNADDRIGMTPLHLAAIGGHLEIVEVLLKNGADVNADDVHGRTPLHLAAGRGHLEIVEVL--HGADVNAPDRWGRTPLHLAAHHGHLEIVEVLLKYGADVNAQDKFGKTAFDISIDSGNEDLAEILQSSGSGGGGSASDLGKKLLEAARAGQDDEVRILMANGADVNATDHLGVTPLHLAAVLGHLEIVEVLLKHGADVNAYDLGRTPLHLAAWRGHLEIVEVLLKYGADVNADDTSGTTPLHLAGHLEIVEVLLKYGADVNA 304
5 -80.0005le9_A mol:protein length:324 DD_Off7_09_3G124  ali model follow..  34  1MRGSGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVSAQDKFGKTPRDLARDNGNEWIVEKLIKAGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDIGHTPLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 318
6 -79.9005ma9_A mol:protein length:305 R11  ali model follow..  33  2XXGPGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADDVGVTPLHLAAQRGHLEIVEVLLKYGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHRAAW-GHLELVEKLLKNGADVNAADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDAGFTPLHLAAIFGHLEIVEVLLKNGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 305
7 -79.8005le7_A mol:protein length:328 DD_D12_13_D12  ali model follow..  34  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPEDLAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 322
8 -79.7005lem_A mol:protein length:326 DD_Off7_11_3G124  ali model follow..  34  1MRGSGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGALVKAKDKFGKTPKDLARDNGNQFIVEEFIKRGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDIGHTPLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 320
9 -79.6005ma5_A mol:protein length:302 K11  ali model follow..  34  1..GPGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADDVGVTPLHLAAQRGHLEIVEVLLKYGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHKAAW-GHLEKVEDLLKNGADVNAADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDAGFTPLHLAAIFGHLEIVEVLLKNGADVNAQDKFGKTPFDLAGNEDIAEILQKAA..... 302
10 -79.5005le4_A mol:protein length:326 DD_D12_11_D12  ali model follow..  33  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGALVKAKDKFGKTPKDLAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 320
11 -79.5005le8_A mol:protein length:330 DD_D12_15_D12  ali model follow..  30  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVRAQDKFGKTPKDLARDNGNEWIRELLEKAERKLK----DLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDRGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAGHLEIVEVLLKHGADVNA 296
12 -79.0005lw1_A mol:protein length:326 DD_232_11_D12  ali model follow..  34  1MRGSGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNASDQLGITPLHLVAITGHLEIVEVLLKNGADVNAHDFVGTTPLHLAAFLGHLEIVEVLLKYGADVNAVDRDGLTPLHLAAIHGHLEIVEVLLKHGALVKAKDKFGKTPKDLAAREGHRDRVEEFIKRGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 320
13 -78.8006by9_A mol:protein length:328 Histone-lysine N-methyltransferase EHMT1  ali model follow..  24  27PTGPAGLGRPT----PGLSQGPGKETLESALIALD-SEKPKKLRFHPKQLYFSARQGELQKVLLMLVDGIDPNFEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGMDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNHGDSPLHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASQVWSALQMSKALQDSA. 328
14 -78.7005y4e_A mol:protein length:277 Ankyrin-2,Ankyrin-2  ali model follow..  26  6....................................LRPEDLKELGDDSLPSSQFLDGMNYLRYSLEGGRSLGSGSRNGITPLHVASKRGNTNMVKLLLDRGGQIDAKTRDGLTPLHCAARSGHDQVVELLLERGAPLLARTKNGLSPLHMAAQGDHVECVKHLLQHKAPVDDVTLDYLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVMELLVKYGASIQAITSGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAGQVEVVRCLKVVTEEVTT 277
15 -78.5005lel_A mol:protein length:325 DD_Off7_10_3G124  ali model follow..  35  1MRGSGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVNAQDKFGKTPYDLAARAGHRDEVEDLIKNGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDIGHTPLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 319
16 -78.5005lea_A mol:protein length:327 DD_Off7_12_3G124  ali model follow..  35  1MRGSGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGAAVGAQDKFGKTPKDLAARAGHREEVEKLIKLGADVNAADDVGVTPLHLAAQRGHLEIVEVLLKCGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDIGHTPLHLAAWAGHLEIVEVLLKHGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 321
17 -78.4006f5e_A mol:protein length:325 DD_D12_10_47  ali model follow..  33  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVNAQDKFGKTPYDLATDNGNQWIAELLIKNGADVNAIDAMGLTPLHLAAMRGHLEIVEVLLKYGADVNAEDYYGTTPLRLAAYIGHLEIVEVLLKYGADVNAYDSGTTPLHLAAVLGHLEIVEVLLKYGADVNAQDKFGKTAFDISGNEDLAEILQKLN..... 319
18 -78.4004b93_B mol:protein length:269 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  25  1...................................RQEETKKDYREVEKLLRAVADGDLEMVRYLLEWTEEVSAADPEFCHPLCQCPKCAPAQRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGNTPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNRQRTAVDCAEQNSKLQVVPSCVASLDDVAETDRKEYVTVKIR.................. 262
19 -77.9003d9h_A mol:protein length:285 cDNA FLJ77766, highly similar to Homo sapiens ankyrin repeat and SOCS box-containing 9 (ASB9), transcript variant 2, mRNA  ali model follow..  26  3.........................SSSSGLVPRG-SHMASMDG-KQGGMDGSKPAGPRDFPGIRLLSNPLMG-DAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQGKGQDSPLHAVVRTASEELACLLMDFGADTQAKNAEGKRPVELVPPESAQLFLEREGASLPK 276
20 -77.6005ma4_A mol:protein length:298 K7  ali model follow..  34  1..GPGSDLGKK----LLEAARAGQDDEVRILMANG-ADVNAADDVGVTPLHLAAQRGHLEIVEVLLKYGADVNAADLWGQTPLHLAATAGHLEIVEVLLKNGADVNARDNIGHTPLHLAAWAGHLEIVEVLLKYGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKGGGDVNAYDEVGWTPLHKAAW-GHLEKVEDLLKNGADVNAADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDAGFTPLHLAAIFGHLEIVEVLLKNGADVNAQDKFGKTPFDLAGNEDIAEVLQKAA..... 298
21 -76.8004qfv_A mol:protein length:234 ANK-N5C-281  ali model follow..  36  2..........................................SMDIGKKLLEAARAGHDDSVEVLLKKGADINAKDNSGRTPLHVAALNGHLELVKLLLEKGADINARDMFGLTPLHTAASNGHLELVKLLLEKGADINARDEDGSTPLHLAASNGHLELVKLLLEKGADINAEDHSGTTPLHFAAKNGHLELVKLLLEKGADINASDFSGPTPLHSAAENGHLELVKLLLEKGADINARDKGKTPFDLAIDNGNEDIAEVLQKAARS................................. 228
22 -76.7004o60_A mol:protein length:234 ANK-N5C-317  ali model follow..  34  2..........................................SMDIGKKLLEAARAGHDDSVEVLLKKGADINAKDNVGVTPLHLAAVNGHLELVKLLLEKGADINATDLFGLTPLHFAATNGHLELVKLLLEKGADINAVDDVGVTPLHFAARNGHLELVKLLLEKGADINAMDMVGPTPLHFAAKNGHLELVKLLLEKDADINAEDHFGSTPLHSAAENGHLELVKLLLEKGADINARDKGKTPFDLAIDNGNEDIAEVLQKAARS................................. 228
23 -75.4002f8x_K mol:protein length:256 Neurogenic locus notch homolog protein 1  ali model follow..  23  4VNVRGPDGFTPLMETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRADLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQLHG.......................................................... 256
24 -75.4001s70_B mol:protein length:299 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130)  ali model follow..  23  1MKMADAKQKRN----EQLKRWIGSETDLEPPVVKR-KKTKVKFDDG-AVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRGVDIEAARKEEERIM-------LRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE-DILGYLEELQKKQNL 289
25 -75.0004nik_A mol:protein length:230 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  26  1....................................................................GSHMMEGCVSNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDEGNTPLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAGLGLILKRMVEG...... 230
26 -74.4004rlv_A mol:protein length:910 Ankyrin-1, Ankyrin-2  ali model follow..  29  362LLARTKNGLSP----LHMAAQGDHVECVKHLLQHK-APVDDVTLDYLTALHVAAHCGHYRVTKLLLDKRANPNARALNGFTPLHIACKKNRIKVMELLVKYGASIQAITESGLTPIHVAAFMGHLNIVLLLLQNGASPDVTNIRGETALHMAARAGQVEVVRCLLRNGALVDARAREEQTPLHIASRLGKTEIVQLLLQHMAHPDAATTNGYTPLHISAREGQVDVASVLLEAGAAHSLATKGFTPLHVAAKYGSLDVAKLLLQRRAAADSAGKNGLTPLHVADNQKVALLLLEKGASPHA 661
27 -74.3003utm_A mol:protein length:351 Tankyrase-1  ali model follow..  27  17AVLTGEYKKDE----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN--EAVQQILSESTPMRT 336
28 -73.9005et0_A mol:protein length:354 Espin  ali model follow..  28  31PSLRDSLDALP----VHHAARSGKLHCLRYLVEEVALPAVSRARNGATPAHDAAATGYLSCLQWLLTQGCRVQEKDNSGATVLHLAARFGHPDVVKWLLYQGANSAITTDTGALPIHYAAAKGDLPSLKLLVGHYPGVNAQTNNGATPLYLACQEGHLEVTKYLVQESADPHLRAQDGMTPLHAAAQMGHNPVLVWLVSFAVSFSEQDHDGATAMHFAASRGHTKVLSWLLLHGAEISQDLWGGTPLHDAAENGELECCQILAVNGAGLDVRDHDGYTAADLAGHTHCSRYLRTQTLSLEH 336
29 -73.9001n11_A mol:protein length:437 Ankyrin  ali model follow..  28  73VNAKAKDDQTP----LHCAARIGHTNMVKLLLENN-ANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAGHTDIVTLLLKNGASPNE 372
30 -73.5001ot8_A mol:protein length:239 Neurogenic locus Notch protein  ali model follow..  26  2.......GLTP----LMIAAVRGGGLDTGEDIE-------------------NNEDSTAQVISDLLAQGAELNATDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNATNLNARMHDGTTPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDHDRLPRDVASERLHHDIVRLLDEH.................................... 239
31 -73.1002dvw_A mol:protein length:231 26S proteasome non-ATPase regulatory subunit 10  ali model follow..  21  1........................................MEGCVSNIMICNLAYSGKLDLKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGASIYIENEEKTPLQVAK--GGLGLILKRLAEGEEASM.............................. 231
32 -72.7001yyh_A mol:protein length:253 Notch 1, ankyrin domain  ali model follow..  25  1....................................MDVNVRGPDGFTPLMIASCSGG--------------------GLETGNSEEEEDAPAVISDFIYQGASLNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRADLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAMHHDIVRLLDLE...... 245
33 -72.3003eu9_A mol:protein length:240 Huntingtin-interacting protein 14  ali model follow..  27  1.....................................HMTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHVDPTRLLLTFNVSVNLGDKHKNTALHWAVLAGNTTVISLLLEAGANVDAQNKGESALDLAKQRKNVWMINHLQEARQAKGYDN............................ 240
34 -72.2004uuc_A mol:protein length:226 ANKYRIN REPEAT AND SOCS BOX PROTEIN 11  ali model follow..  25  1...........................................................................SMADRSPLHEAAAQGRLLALKTLIAQGVNVNLVTINRVSSLHEACLGGHVACAKALLENGAHVNGVTVHGATPLFNACCSGSAACVNVLLEFGAKAQL-EVHLASPIHEAVKRGHRECMEILLANNVNIDHEVPQLGTPLYVACTYQRVDCVKKLLELGASVDHGQWLDTPLHAAARQSNVEVIHLLTDYGANLKRRNAQGKSALDLASSVEQALLLREGPPAL.. 226
35 -72.0005le2_A mol:protein length:491 DDD_D12_15_D12_15_D12  ali model follow..  30  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVRAQDKFGKTPKDLARDNGNEWIRELLEKAERKLK----DLDRKLLEAARAGHRDEVEDLIKNGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDRGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAGHLEIVEVLLKNGADVRA 296
36 -71.7005lec_A mol:protein length:485 DDD_D12_12_D12_12_D12  ali model follow..  33  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGAAVGAQDKFGKTPKDLARDNGNQWIVEKLIKLGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKNGAAVGAQDKFGKTPKDLAGNQWIYELLEKAEKDLRR 326
37 -71.7002qc9_A mol:protein length:210 Notch 1 protein  ali model follow..  25  2.........................SVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILLRNRADLDARMHDGTTPLILAARLALEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNKEETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEY.................................................................... 210
38 -71.7006fes_A mol:protein length:367 D12_BRIC2, a synthetic protein,D12_BRIC2, a synthetic protein  ali model follow..  24  1..GPGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHEEIVEVLLKNGADARAQDKFGKTPEDLARDNGYESVARLARKEIIRAEITETMGFSPVALVLE-AIMMLVKLMLNSEIKI--------TSDLIDAVKKMLDMVTRLLDLMVDPNLNEEQYIKMVVDALKILIEAVNVLIK-MVEKNPEDMEFWNLIYRLGFSSVAKVLHTIMNLVDK 335
39 -71.6005w7i_A mol:protein length:239 Palmitoyltransferase ZDHHC17  ali model follow..  27  1....................................................................GPHMKTHDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHVDPTRLLLTFNVSVNLGDKKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKNVWMINHLQEARQA... 238
40 -71.4004g8k_A mol:protein length:337 2-5A-dependent ribonuclease  ali model follow..  26  27.............HLLIKAVQNEDVDLVQQLLEGG-ANVNFQEEEGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFILAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGANVNLRRKGGATALMDAAEKGHVEVLKILLDEGADVNACDNMGRNALIHALLSSDDSITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQHIEINDTDDGKTALLLAVELKLKKIAELLCKRGASTD-----CGDLVMTAYDHSLVKVLLSHGAKEDF 329
41 -71.3003ljn_A mol:protein length:364 hypothetical protein  ali model follow..  18  13RIKSDDENMEK----IHVAARKGQTDEVRRLIETG-VSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH--GQKPIHLAVMANKTDLVVALVEGAKESHVKHCKGQTALHWCVGLGYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQAVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTGAGGAVKRAAPAVKRMKLAPSAPVRT 351
42 -71.0005leb_A mol:protein length:473 DDD_D12_06_D12_06_D12  ali model follow..  32  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTPFDLARDNGNEWIVEKLMANGADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDIGTAPLHLAAMWGHLEIVEVLLKNGADVFAQDKFGKTPFDLAGQRDRVEKLMANGADVNT 340
43 -69.6003kea_A mol:protein length:285 K1L  ali model follow..  16  2.............MDLSRINTWKSKQLKSFLSS---KDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGKTSFYHAVMLNDVSIVSYFLSEIPSTF-DLAILLSCIHITIKNGHVDMMILLLDYMTSTNTNNSLLFIPIKLAIDNKDIEMLQALFKYDINIYSA-NLENVLL-----DDAEIAKMIIEKHVEYK--SDSYTKDLDIVKLDEIISKNKELRLMYVN 280
44 -69.5001oy3_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  21  2FGYVTEDGDTA----LHLAVIHQHEPFLDFLLGFSAEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDSHAPAAVDSQPNPENEEERDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPETCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGDKLSPCSSSGSDSDSDNRDEGDEYD................................... 281
45 -69.3005g4x_A mol:protein length:348 SH3 AND MULTIPLE ANKYRIN REPEAT DOMAINS PROTEIN 3  ali model follow..  18  21TKCLRLDPTAPVNYGLFQPPSRGR---AGKFLDEE-RLLQDYPPNLDTPLYLEFRYKRRVYAQNLIDDKQFAKLHTKANLKKFMDYVQLHSTDKVARLLDKGLDPNFHDDSGECPLSLAAQDNATDLLKVLRNGGAHLDFRTRDGLTAVHCATRQRNAGALTTLLDLGASPDYKDSRGLTPLYHSALGGGALCCELLLHDHAQLGTTDENGWQEIHQACRFGHVQHLEHLLFYGANMGAQNSGNTALHICALYNQESCARVLLFRGANKDVRNYNSQTAFQVAGNFELAEVIKTHKDSDVV 344
46 -69.3005vkq_A mol:protein length:1732 No mechanoreceptor potential C isoform L  ali model follow..  25  228..KADGRGKIP----LLLAVESGNQSMCRELLAAQAEQLKATTANGDTALHLAARRRDVDMVRILVDYGTNVDTQNGEGQTPLHIAAAEGDEALLKYFYGVRASASIADNQDRTPMHLAAENGHAHVIEILADKKASIFERTKDGSTLMHIASLNGHAECATMLFKKGVYLHMPNKDGARSIHTAAAYGHTGIINTLLQKGEKVDVTTNDNYTALHIAVESAKPAVVETLLGFGADVHVRGGRETPLHIAARVKDGDCALMLLKSGASPNLTTDDCLTPVHVAGNLATLMQLLEDEGDPLY 530
47 -69.2001k3z_D mol:protein length:282 transcription factor inhibitor I-kappa-B-beta  ali model follow..  21  2FGYVTEDGDTA----LHLAVIHQHEPFLDFLLGFSAEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDASDSHAPAAVDSQPNPENEEERDEDWRLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPETCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGDKLSPCEEEGEDEDSDNRDEGDEYD................................... 281
48 -68.4005jhq_A mol:protein length:482 Tankyrase-1  ali model follow..  28  40VNAKDMAGRK--SSPLHFAAGFGRKDVVEHLLQMG-ANVHARDDGGLIPLHNACSFGHAEVVSLLLCQGADPNARDNWNYTPLHEAAIKGKIDVCIVLLQHGADPNIRNTDGKSALDLADPSAKAVLMALLTPLNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNRVEVCSLLLSHGADPTLVNSHETALHCAVASLHKQVTELLLRKGANVNEKNKDFMTPLHVAAHNDVMEVLHKHGAKMNA 419
49 -68.4005aq8_A mol:protein length:426 OFF7_DB12V4  ali model follow..  24  1MRGSGSDLGRK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDAAGVLLTAAKVKDAADQLGARVGYIELDLNSGKILASVRELASAAITMSDNTAANLLLTTIGGPKGLTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTPASRQQLMDWMEADKVAGPLLRS 355
50 -68.3005d66_A mol:protein length:198 Uncharacterized protein  ali model follow..  27  2............................................KDEYPLHMAAANDDIQLIKHILSQKTLIDARDETGSTALMVATRANNIHAAHMLIEAGADVNAKDNIQDSPYLYAGAQGYLKILRMTLMHGADLKSTNRYGGTALIPAAERGHVETVRTLIAAGVNVNHVNNLGWTALLEAIKSNYQQIVALLLKAGANPNLADKDGITPLQHARTRGYREIEKLLLVAGAK................................................................. 198
51 -68.2006c9k_A mol:protein length:319 DARP14 - Subunit A with DARPin  ali model follow..  22  14RLFGGEEVWKD----SPIIEANGTLDELTSFIGEA-KHYVDEEMKGKGKIEGISEERIAWLLKLILRYMEMVNL---KSFVLPGGTLESAKLDVCRTIARRALRVLTVTREFGIGAEAAAYLLALSDLLFLLARVIEIE-----LGKKLLEAARAGQDDEVRILMANGADVNAHDDQGSTPLHLAAWIGHPEIVEVLLKHGADVNARDTDGWTPLHLAADNGHLEIVEVLLKYGADVNAQDAGLTPLHLAADRGHLEIVEVLLKHGADVNAQDKFGKTAFDISGNEDLAEILQKLN..... 319
52 -68.2003j9p_D mol:protein length:1528 Maltose-binding periplasmic protein, Transient receptor potential cation channel subfamily A member 1 chimera  ali model follow..  21  525PNLRNFNMMAP----LHIAVQGMNNEVMKVLLEHRTIDVNLEGENGNTAVIIACTTNNSEALQILLKKGAKPCKSNKWGCFPIHQAAFSGSKECMEIILRFGEEINFMNNGKATPLHLAVQNGDLEMIKMCLDNGAQIDPVEKGRCTAIHFAATQGATEIVKLMISSYSGVNTTDGCHETMLHRASLFDHHELADYLISVGADINKIDSEGRSPLILATASASWNIVNLLLSKGAQVDIKDDGCTPLHYACRQGGPGSVNNLLGFNVSIHSKSKDKKSPLHFAGRINTCQRLLQDISDTRL 875
53 -68.2005aqa_A mol:protein length:418 OFF7_DB04V3  ali model follow..  24  1MRGSGSDLGRK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYKEIVEVLLKAGADVDAQDKFGKRPLWLAADQGHAEIAAKLVAARLKARVGYIELDLNSGKIVTEKHLTDGMTVRELASAAITMSDNTAANLLLTTIGGPKGLTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTPASRQVAGPLLRSVLPAGWFIAD 357
54 -67.8003zng_A mol:protein length:268 ANKYRIN REPEAT AND SOCS BOX PROTEIN 9  ali model follow..  22  2............................................SDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLASPIHEAARRGHVECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVNQ-GKGQDSPLHAVARTASEELACLLMDFGADTQAKNEGKRPVELVPPESP--LAQLFLEREGPPSLMQLCRLRIRKCFQHHKITKLVLPEDLK... 255
55 -67.4005aq7_A mol:protein length:418 D12_DB04V3  ali model follow..  24  1MRGSGSDLGKK----LLEAARAGQDDEVRILLANG-ADVNTADETGFTPLHLAAWEGHLGIVEVLLKNGADVNANDERGHTPLHLAAYTGHLEIVEVLLKNGAGVNATDVIGTAPLHLAAMWGYKEIVEVLLKAGADVDAQDKFGKRPLWLAADQGHAEIAAKLVAAAGAILSRIDAGQEQLGRRIHYSQNDLVMTVRELASAAITMSDNTAANLLLTTIGGPKGLTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPVAMATTLRKLLTGELLTPASRQEADKVAGPLLRSVLPAG. 352
56 -67.4004cym_D mol:protein length:203 ANKYRIN REPEAT DOMAIN-CONTAINING PROTEIN 27  ali model follow..  28  2..........................PLGSMDPSV-VTPFSRDDRGHTPLHVAAVCGQASLIDLLVSKGAMVNATDYHGATPLHLACQKGYQSVTLLLLHYKASAEVQDNNGNTPLHLACTYGHEDCVKALVYYDVELDIGNEKGDTPLHIAARWGYQGVIETLLQNGASTEIQNRLKETPLKCALNSKI---LSVMEAYHLSFERRQKSSEAPVQSPQRSVD.............................................................................. 197
57 -67.1005aqb_A mol:protein length:428 3G61_DB15V4  ali model follow..  23  1MRGSGSDLGKK----LLEAARAGQDDECRILMANG-ADVNALDEVGWTPLHLAAW-GHLEIVECLLKNGADVNAADIDGYTPLHLAAFSGHLEIVEVLLKYGADVNADDQAGFTPLHLAAIFGHLEIVEVLLKNGADVNAQDKFGKTPRDLAIDNGNEDIAEVLGKAATLVKVKDAADQLGARVGYIELDLNSGKILESFRSEERFPMMSTFKVLLAGAILSRIDAGQEQLGRRIHYSQNDVEYSPVTEKHLTDGMTVRELASAAIT----MSDNTAANLLLTGPKGLTAFLHNMGDHVTR 295
58 -67.0005aar_A mol:protein length:185 POTASSIUM CHANNEL AKT1  ali model follow..  28  3...............................................LNLCFAAIREDDLLLHQLLKRGLDPNESDNNGRTPLHIAASKGTLNCVLLLLEYHADPNCRDAEGSVPLWEAMVEGHEKVVKVLLEHGSTIDAGDVGHFACT--AAEQGNLKLLKEIVLHGGDVTRPRATGTSALHTAVCEENIEMVKYLLEQGADVNKQDMHGWTPRDLAEQQGHEDIKALFRE..................................................................... 185
59 -66.9001k1a_A mol:protein length:241 B-cell lymphoma 3-encoded protein  ali model follow..  25  2......................................ATRADEDGDTPLHIAVVQGNLPAVHRLVNGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAADLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNHNDTPLMVARSRRVIDILRGKATRPAS................................. 241
60 -66.8005h76_A mol:protein length:201 DARPin,Immunoglobulin G-binding protein A  ali model follow..  29  2.........................................SHMDLGRKLLEAARAGQDDEVRILMANGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGA-VNAQDKFGKTAFDISIDNGNEDLAQILAFYEIHLPNLNEEQRNAFIQSLKDDPSQSANLLAEAKKLNDAQA............................................................ 201
61 -66.6005cea_A mol:protein length:230 Bd3460  ali model follow..  26  1.................MKKSYLLAALIFFLAGLLHGTAFAMSGKSSKALNEAAEQGDLAKVKNLVQKNKDLNAQDETGMTPLMNAAMGGNLDIVKFLLSKKVNLELKNNGGETALAFAVTNDAYDVAEELIKAGANVDIAGDEGDTLFMRAAQNNKKTAESILAKNKSLINKANTLGETALFAVARYGTPADIDFLIKKGADLKLKNKKGQTALDVAKEASNQDTAKALSKKKLE................................................................. 222
62 -66.6005aq9_A mol:protein length:422 OFF7_DB08V4  ali model follow..  24  1MRGSGSDLGRK----LLEAARAGQDDEVRILMANG-ADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAYWGHLEIVEVLLKNGADVNAMDSDGMTPLHLAAKWGYLEIVEVLLKHGADVNAQDKFGKTPFDLADDNGNDDVGTLLQVAAAADQLGARVGYIELDLNSGKILESMSTFKVLLAGAILSRIDAGQEQLYSPVTEKHLTDGMTVRELASAAITSDNTAANLLLTTIGGPKGLTAFLHNMGDHVTRLDR-WEPELNEADERDTTTPVAMATT.... 317
63 -66.6001wg0_A mol:protein length:243 Probable 26S proteasome regulatory subunit p28  ali model follow..  18  2.............................................SNYPLHQACMENEFFKVQELLSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLPDDSGWTPFHIACSVGNLEVVKSLYDRPPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGSAVNWQDKQGWTPLFHALAEGHGDAAVLLVE-------------------------------KYGAEYDLVDNKGAKAEDVALNEQVKKFFLNNVVDKLA 233
64 -66.5001ycs_B mol:protein length:239 53BP2  ali model follow..  19  2....EITGQVS----LPPGKRTNLRKTGSERIAHG-MRVKF-NPLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDMADKCEEMEEGYTQCSQFLYGVQEKMGIMNKGVIYALWDYEPQNDDEL---PMKEGDCMTIIHREDEDEIEWWWAR----------------LNDKEGYVPRNLLGLYPRIKPRQRSLA..................................... 239
65 -66.3001ikn_D mol:protein length:236 PROTEIN (I-KAPPA-B-ALPHA)  ali model follow..  21  2.......................................QQLTEDGDSFLHLAIIHEEMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTLKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLESEDEESYDTESEFTEFTE......................................... 234
66 -66.0004hbd_A mol:protein length:276 KN motif and ankyrin repeat domain-containing protein 2  ali model follow..  19  1................MGSSSSGRENL---YFQGSGSNTEEEIRMELSPDLISALEKYLDNPNALTERELKVAYTTVLQEWLRLACRSDAHPELVRRHLVTFYVVNIADSNGNTALHYSVSHANFPVVQQLLDSGCKVDKQNRAGYSPIMLTATQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVSCDISLTDDGSTALMVALDAGQSEIASMLYSRMN.................................. 268
67 -65.7006aun_A mol:protein length:752 PLA2G6, iPLA2beta  ali model follow..  18  145NSTENEEGCTP----LHLACRKGDSEILVELVQYCHAQMDVTDNKGETAFHYAVQGDNSQVLQLLGKNAAGLNQVNKQGLTPLHLACQMGKQEMVRVLLLCNARCNVMGPSG-FPIHTAMKFSQKGCAEMIISMDSSQSKDPRYGASPLHWAK---NAEMARMLLKRGCDVDSTSAAGNTALHVAVMRNRFDCVMVLLTYGANAGTPGEHGNTPLHLAISKDNMEMIKALIVFGAEVDTPNDGETPAFMASKISKQLQDLMPISRARKPAFILSSMRDEKRIHGGGVKGLVIIQLLIAIEK 448
68 -65.7002rfm_A mol:protein length:192 Putative ankyrin repeat protein TV1425  ali model follow..  23  2..................SHMDKNGEIVEKIKDEKSFLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGLTAEASARIFGRQEVIKIFTEVRR................................................................................................... 191
69 -65.6005mla_B mol:protein length:187 darpin k55  ali model follow..  33  1.................................................................MGSSGHIEGRHMDLGKKLLEAARAGQDDEVRILMANGADVNANDSAGHTPLHLAAKRGHLEIVEVLLKHGADVNAMDNTGFTPLHLAALRGHLEIVEVLLKNGADVNAQDRTGRTPLHLAAKLGHLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQK-LYPYDVPDYA.......................................................... 177
70 -65.6002vge_A mol:protein length:229 RELA-ASSOCIATED INHIBITOR  ali model follow..  17  1.............................................................MRSVLRKAGSPRKARRARLNPLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTSDGATAFEKCYREGYADCATYLADVEQSMGLMNSGAVYALWDYSAEFG-DELSFREGESVTVLRRDGEETDWWWAALHGQEGYVRNYFGLFPRVKPQRSKVK........................ 223
71 -65.4005mlb_B mol:protein length:178 DARPin K27  ali model follow..  35  1.................................................................MGSSGHIEGRHMDLGKKLLEAARAGQDDEVRILMANGADVNAHDTFGFTPLHLAALYGHLEIVEVLLKNGADVNADDSYGRTPLHLAAMRGHLEIVEVLLKYGADVNAADEEGRTPLHLAAKRGHLEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQK..................................................................... 167
72 -65.1006fp8_B mol:protein length:182 DARPin1238_E11  ali model follow..  34  1......................................MRGSGSDLGKKLLEAARAGQDDEVRILMANGADVNATDWVGMTPLHLAAWKGHLEIVEVLLKTGADVNAHDVFGTTPLHLAAHRGHLEIVEVLLKAGADVNAQDMVGKTPLHLAAYYGHLEIVEVLLKHGADVNAQDKFGKTPFDLAIDNGNEDIAEVLQKAAKLNDYKDDDDK......................................................................................... 174
73 -65.1005ybe_A mol:protein length:286 Kank1 protein  ali model follow..  18  1.......GPGSEFEPEKEEIR-ERYELSEKML----SACNLLKYNIKDPKALASKDMRICLNTLQHD---WFRVSSQKSAVPAMVGDYIAAFEAVSPDVL-RYIINMADGNGNTALHYSVSHSNFQIVKLLLDADVNVDHQNKAGYTPIMLAAAEKDMQVVEELFSCGDVNAKASQAGQTALMLAVSHGRIDMVKGLLACGADVNIQDDEGSTALMCASEHGHVEIVKLLLAQGCNGHLEDNGSTALSIALEAGHKDIAVLLYASKAQSPSTPRLGRKTSPGPGSFD.............. 286
74 -65.0006emk_G mol:protein length:426 Target of rapamycin complex 2 subunit AVO2  ali model follow..  17  2....LKEPSVR----LREAIIEGNLLIVKRLLRRNDLLTNIDSENGWSSLHYASYHGRYLICVYLIQLGHDKHIKTFKGNTCVHLALMKGHEQTLHLLLQQFPRINHRGENGRAPIHIACMNDYYQCLSLLIGVGADLWVMDTNGDTPLHVCLEYGSISCMKMLLNEGEDDNVRDKGNWKPIDVAQTNIYSKVLKEVKKKGPPLGAKPSSFRTPILNAKATFE-DGPSPVLSMNSPYSLYSNSPLPVLPRRISTHTTSGNGGNRRSSITNPVFNPRKPTLSTDSSSNSSSRLRVNSINVKT 310
75 -65.0002fo1_E mol:protein length:373 Lin-12 protein  ali model follow..  17  30NHQSITSSQHSLLEASLYPNPQGYGNGNDFLGDFNHTLQIPTEPEPESPIKLHTEAGSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSKGDIEELDRNGMTALMIVAHNEGVASAKLLVEKGAKVDSEKYKGRTALHYAAQVSNMPIVKYLVEKGSNKDKQDDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLANHHNIVDIFDRCRPERE. 373

FFAS is supported by the NIH grant R01-GM087218-01
1 4 7 6 2 8   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Friedberg I, Godzik A. Fragnostic: walking through protein structure space. Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W249-51.